Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Filter Results

1238 News Releases Found

Jonathan D. Schoenfeld, MD, MPhil, MPH
News Releases
1/13/2022

Immunotherapy Combination Shown to Benefit Some Patients with Non-Small Cell Lung Cancer Resistant to Single Immunotherapy

  • Lung Cancer, non-small cell
Bacterial gasdermin pores populating the surface of a synthetic liposome. Image credit: Megan Mayer and TomoTrace from Ariadne.ai.
News Releases
1/13/2022

Research shows that human immune system uses ancient family of cell death proteins also found in bacteria

  • Research
Micrograph of Barrett's esophagus
News Releases
1/13/2022

A case of mistaken identity: Researchers unmask cellular source of Barrett’s esophagus

  • Research
  • Esophageal Cancer
Goldie Taylor
News Releases
1/6/2022

Goldie Taylor named Senior Vice President, Chief Communications and Marketing Officer

F. Stephen Hodi, Jr., MD
News Releases
1/6/2022

Immunotherapy combination shows significant benefit for patients with advanced melanoma

  • Discovery
  • Melanoma
Paula and Roger Riney
News Releases
1/6/2022

Paula and Rodger Riney Foundation makes $40 million transformative grant to further multiple myeloma research at Dana-Farber Cancer Institute

  • Multiple Myeloma
Novel Coronavirus SARS-CoV-2
News Releases
12/24/2021

Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate

  • Research
Leslie S. Kean, MD, PhD
News Releases
12/15/2021

FDA approval offers hope for prevention of acute graft-versus-host disease

  • Discovery
  • Stem Cell/Bone Marrow Transplant, Childhood
_
News Releases
12/15/2021

Dana-Farber/Boston Children’s Cancer and Blood Disorders Centers launches redesigned web site

  • Blood Disorders, Childhood